COH STOCK ANALYSIS

Cochlear Ltd — price, returns and risk statistics

COHCochlear Ltd

🇦🇺 Australia · AU · Healthcare · Medical Devices

Value itDuel

Price summary

Last Close

124.96 A$

Jul 3, 26

Market Cap

8.2 B A$

Q2 2025 (TTM)

52-Week Range

90.00 A$313.15 A$

Return and risk cards

Total Return

%-57.7

Trailing 1-year performance

Volatility

%51.3

Price fluctuation measure

Sharpe Ratio

-2.12

Risk/Return ratio

Sortino Ratio

-1.65

Downside risk/return

Distance to Peak

%-60.1

Difference from 52-week peak

Maximum Drawdown

-%71.3

Deepest 1-year decline

Seasonality

Seasonality Chart

Year 2023
Year 2024
Year 2025
Current Period 2026
3/3 positive months

Periodic Returns

1M

+31.4%

3M

-27.5%

6M

-51.5%

YTD

-51.5%

1Y

-57.7%

3Y

-42.9%

Returns are computed from split-adjusted closes; dividends are not included.

YTD Return — Stock vs Asset Classes

Year-to-date
COH-51.5%Gold-6.1%Silver-13.1%S&P/ASX 200+1.3%

Stock and gold/silver returns are in AUD (metals converted into the stock's currency). The S&P/ASX 200 index is measured in its own currency.

Monthly positivity

Monthly Avg Positive/Negative Close

Positive Count
Negative Count
Average Positive %
Average Negative %

Frequently Asked Questions

What is the current Cochlear Ltd (COH) stock price?

COH last closed at 124.96 A$ (Jul 3, 26). Price data is refreshed after every trading day.

What is the P/E ratio of COH?

Cochlear Ltd trades at a trailing-twelve-month P/E of 23.72. See the comparison tables on the Peers tab for the industry context.

What is the market capitalization of Cochlear Ltd?

Cochlear Ltd (COH) has a market capitalization of approximately 8.2 B A$ as of the latest reported period.

Who are the main competitors of COH?

Key peers of Cochlear Ltd include LivaNova PLC, iRhythm Technologies Inc, Bio-Rad Laboratories Inc, Glaukos Corp, Haemonetics Corporation. A detailed metric comparison is available on the Peers tab.

Go deeper on COH

Data on this page refreshes once per day. Price data as of Jul 3, 26. This content is for informational purposes only and is not investment advice.